Latest Research

SUBSTACK FEED

Light-guided Algae Microrobots Deliver Cancer Drugs And Mushroom Based Electronic Circuits - Bio Nanotechnology Updates And Correlation To Human Live Blood

Micro Robots In Cats Live Virus Rhinotracheitis and Panleukopenia Vaccine

Dr Hildegarde Staninger in 2006 Explains Link Between Nanobots, Chemtrails and Morgellons - Explains Why These Are Not Parasites, But Man-made From Polyester and Silica/ Silicone: Must See

CIA Whistleblower Reveals Biden Admin Covered Up Attacks on Officers Injured by Direct Energy Weapons

Happy Holidays and A Fantastic New Year 2025!

UN Warns of Military Brain Control - Discussion of Dangers of Brain Computer Interface And Possibility Of Human Rights Violations

Carnicom Institute

Clifford Carnicom has researched the phenomenon of bioengineering with nanotechnology and synthetic biology by investigating the phenomenon of Morgellons, which he renamed Cross Domain Bacteria (CDB). Clifford and I became research partners to investigate the correlations between the C19 nanotechnological weapons and CDB/Morgellons.

Discover Carnicom Institute →

Rumble Videos

On this channel interviews with many different interesting scientists are featured, bringing forward new scientific understandings of healing, medicine, science and the investigation of C19 bioweapons.

Subscribe on Rumble →

Top Interviews

Evidence of Crimes Against Humanity - Darkfield Blood Microscopy

In this interview with SGT Report, Dr. Ana explains the evolution of information of nanotechnology and synthetic biology found initially in the C19 vials, then in human blood.

Watch this Interview

Healing From Mind Control Through Love

Mindful Protection from Nanotechnological and Synthetic Biology Assault: Dr. Ana Mihalcea & CIA MK-ULTRA Survivor and Whistleblower Cathy O'Brien

Watch this Interview

AI Exterminating Humans Through Synthetic Biology

Karen Kingston & Dr. Ana Mihalcea join Maria Zeee to expose their correlating findings that confirm our hypothesis regarding the transhumanist agenda.

Watch this Interview